Welltower Reports Third Quarter 2018 Results
Quarterly Highlights
- Increased normalized 2018 FFO guidance to
$4.02 to$4.07 per diluted share from$3.99 to$4.06 per diluted share - Successfully completed over
$2.1 billion of health system and outpatient medical gross investments, and announced a further$480 million of agreements to acquire high quality outpatient medical buildings - Successfully closed
$1.3 billion senior unsecured notes offering across three tranches with a weighted average maturity of 15.4 years and blended yield to maturity of 4.4% - Delivered
$96 million of pro rata development projects with an expected stabilized yield of 8.5% - Named to the Dow Jones Sustainability World Index for the first time and the Dow Jones Sustainability North America Index for the third consecutive year
- Recognized by the
National Diversity Council as one of the top 10 Diverse Companies inOhio
"
Capital Activity In July, we closed on a new
On
Dividend The Board of Directors declared a cash dividend for the quarter ended
Notable Investments with
Regents of The
Brandywine As previously announced, in
Notable Investments with
Acquisition of
Notable Development Conversions
Notable Dispositions
Genesis We completed the disposition of three long-term/post-acute properties for
Notable Expected Investments
Medical Office Portfolio We have entered into an agreement to acquire a 100% interest in a 23 property, Class-A medical office portfolio for approximately
Outlook for 2018 Net income attributable to common stockholders has been changed to a range of
- Same Store NOI: We continue to expect average blended SSNOI growth of approximately 1.0%-2.0% in 2018.
- Acquisitions: 2018 earnings guidance includes any acquisitions closed or announced year to date.
- Development: We anticipate funding development of approximately
$72 million in 2018 relating to projects underway onSeptember 30, 2018 . - Dispositions: We are reducing anticipated disposition proceeds from
$2.4 billion to$2.2 billion at a blended yield of 6.0% in 2018. This includes approximately$1.4 billion of proceeds from dispositions completed to-date at a blended yield of 6.9%.
Our guidance does not include any additional investments, dispositions or capital transactions beyond what we have announced, nor any other expenses, impairments, unanticipated additions to the loan loss reserve or other additional normalizing items. Please see the exhibits for a reconciliation of the outlook for net income available to common stockholders to normalized FFO attributable to common stockholders. We will provide additional detail regarding our 2018 outlook and assumptions on the third quarter 2018 conference call.
Conference Call Information We have scheduled a conference call on
Supplemental Reporting Measures We believe that net income and net income attributable to common stockholders (NICS), as defined by
Historical cost accounting for real estate assets in accordance with
We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our seniors housing operating and outpatient medical properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations or transaction costs. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. SSNOI is used to evaluate the operating performance of our properties under a consistent population which eliminates changes in the composition of our portfolio. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Land parcels, loans, and sub-leases as well as any properties acquired, developed/redeveloped (including major refurbishments where 20% or more of units are simultaneously taken out of commission for 30 days or more), sold or classified as held for sale during that period are excluded from the same store amounts. Properties undergoing operator transitions and/or segment transitions (except triple-net to seniors housing operating with the same operator) are also excluded from the same store amounts. Normalizers include adjustments that in management's opinion are appropriate in considering SSNOI, a supplemental, non-GAAP performance measure. None of these adjustments, which may increase or decrease SSNOI, are reflected in the company's financial statements prepared in accordance with
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and ratings agencies in the valuation, comparison, rating and investment recommendations of companies. Our management uses these financial measures to facilitate internal and external comparisons to historical operating results and in making operating decisions. Additionally, they are utilized by the Board of Directors to evaluate management. The supplemental reporting measures do not represent net income or cash flow provided from operating activities as determined in accordance with
About
Forward-Looking Statements and Risk Factors This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "pro forma," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to our opportunities to acquire, develop or sell properties; our ability to close anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of our operators/tenants and properties; our expected occupancy rates; our ability to declare and to make distributions to shareholders; our investment and financing opportunities and plans; our continued qualification as a REIT; our ability to access capital markets or other sources of funds; and our ability to meet our earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause our actual results to differ materially from our expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators'/tenants' difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; our ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting our properties; our ability to re-lease space at similar rates as vacancies occur; our ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting our properties; changes in rules or practices governing our financial reporting; the movement of
|
||||||||
Financial Exhibits |
||||||||
Consolidated Balance Sheets (unaudited) |
||||||||
(in thousands) |
||||||||
|
||||||||
2018 |
2017 |
|||||||
Assets |
||||||||
Real estate investments: |
||||||||
Land and land improvements |
$ |
3,193,555 |
$ |
2,806,586 |
||||
Buildings and improvements |
27,980,830 |
26,010,364 |
||||||
Acquired lease intangibles |
1,562,650 |
1,492,279 |
||||||
Real property held for sale, net of accumulated depreciation |
619,141 |
70,995 |
||||||
Construction in progress |
135,343 |
344,742 |
||||||
33,491,519 |
30,724,966 |
|||||||
Less accumulated depreciation and intangible amortization |
(5,394,274) |
(4,826,418) |
||||||
Net real property owned |
28,097,245 |
25,898,548 |
||||||
Real estate loans receivable |
409,196 |
496,850 |
||||||
Less allowance for losses on loans receivable |
(68,372) |
(5,406) |
||||||
Net real estate loans receivable |
340,824 |
491,444 |
||||||
Net real estate investments |
28,438,069 |
26,389,992 |
||||||
Other assets: |
||||||||
Investments in unconsolidated entities |
423,192 |
407,507 |
||||||
|
68,321 |
68,321 |
||||||
Cash and cash equivalents |
191,199 |
236,247 |
||||||
Restricted cash |
90,086 |
59,064 |
||||||
Straight-line rent receivable |
388,045 |
393,142 |
||||||
Receivables and other assets |
650,207 |
626,106 |
||||||
1,811,050 |
1,790,387 |
|||||||
Total assets |
$ |
30,249,119 |
$ |
28,180,379 |
||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Borrowings under primary unsecured credit facility |
$ |
1,312,000 |
$ |
420,000 |
||||
Senior unsecured notes |
9,655,022 |
8,315,395 |
||||||
Secured debt |
2,465,661 |
2,713,513 |
||||||
Capital lease obligations |
71,377 |
72,684 |
||||||
Accrued expenses and other liabilities |
1,074,994 |
1,027,375 |
||||||
Total liabilities |
14,579,054 |
12,548,967 |
||||||
Redeemable noncontrolling interests |
400,864 |
386,748 |
||||||
Equity: |
||||||||
Preferred stock |
718,498 |
718,503 |
||||||
Common stock |
376,353 |
371,012 |
||||||
Capital in excess of par value |
17,889,514 |
17,564,805 |
||||||
|
(68,753) |
(62,363) |
||||||
Cumulative net income |
6,008,095 |
5,416,427 |
||||||
Cumulative dividends |
(10,478,020) |
(9,138,346) |
||||||
Accumulated other comprehensive income |
(138,491) |
(141,240) |
||||||
Other equity |
489 |
1,127 |
||||||
|
14,307,685 |
14,729,925 |
||||||
Noncontrolling interests |
961,516 |
514,739 |
||||||
Total equity |
15,269,201 |
15,244,664 |
||||||
Total liabilities and equity |
$ |
30,249,119 |
$ |
28,180,379 |
Consolidated Statements of Income (unaudited) |
||||||||||||||||||
(in thousands, except per share data) |
||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||
|
|
|||||||||||||||||
2018 |
2017 |
2018 |
2017 |
|||||||||||||||
Revenues: |
||||||||||||||||||
Rental income |
$ |
342,887 |
$ |
362,880 |
$ |
1,019,857 |
$ |
1,085,621 |
||||||||||
Resident fees and service |
875,171 |
702,380 |
2,374,450 |
2,049,757 |
||||||||||||||
Interest income |
14,622 |
20,187 |
42,732 |
61,836 |
||||||||||||||
Other income |
3,699 |
6,036 |
22,217 |
15,169 |
||||||||||||||
Gross revenues |
1,236,379 |
1,091,483 |
3,459,256 |
3,212,383 |
||||||||||||||
Expenses: |
||||||||||||||||||
Interest expense |
138,032 |
122,578 |
382,223 |
357,405 |
||||||||||||||
Property operating expenses |
657,157 |
523,997 |
1,782,373 |
1,536,021 |
||||||||||||||
Depreciation and amortization |
243,149 |
230,138 |
707,625 |
683,262 |
||||||||||||||
General and administrative expenses |
28,746 |
29,913 |
95,282 |
93,643 |
||||||||||||||
Loss (gain) on derivatives and financial instruments, net |
8,991 |
324 |
(5,642) |
2,284 |
||||||||||||||
Loss (gain) on extinguishment of debt, net |
4,038 |
— |
16,044 |
36,870 |
||||||||||||||
Impairment of assets |
6,740 |
— |
39,557 |
24,662 |
||||||||||||||
Other expenses |
88,626 |
99,595 |
102,396 |
117,608 |
||||||||||||||
Total expenses |
1,175,479 |
1,006,545 |
3,119,858 |
2,851,755 |
||||||||||||||
Income (loss) from continuing operations before income taxes |
||||||||||||||||||
and income from unconsolidated entities |
60,900 |
84,938 |
339,398 |
360,628 |
||||||||||||||
Income tax (expense) benefit |
(1,741) |
(669) |
(7,170) |
5,535 |
||||||||||||||
Income (loss) from unconsolidated entities |
344 |
3,408 |
(836) |
(23,676) |
||||||||||||||
Income (loss) from continuing operations |
59,503 |
87,677 |
331,392 |
342,487 |
||||||||||||||
Gain (loss) on real estate dispositions, net |
24,723 |
1,622 |
373,662 |
287,869 |
||||||||||||||
Net income (loss) |
84,226 |
89,299 |
705,054 |
630,356 |
||||||||||||||
Less: |
Preferred dividends |
11,676 |
11,676 |
35,028 |
37,734 |
|||||||||||||
Preferred stock redemption charge |
— |
— |
— |
9,769 |
||||||||||||||
Net income (loss) attributable to noncontrolling interests |
8,166 |
3,580 |
13,539 |
7,735 |
||||||||||||||
Net income (loss) attributable to common stockholders |
$ |
64,384 |
$ |
74,043 |
$ |
656,487 |
$ |
575,118 |
||||||||||
Average number of common shares outstanding: |
||||||||||||||||||
Basic |
373,023 |
369,089 |
372,052 |
366,096 |
||||||||||||||
Diluted |
374,487 |
370,740 |
373,638 |
367,894 |
||||||||||||||
Net income (loss) attributable to common stockholders per share: |
||||||||||||||||||
Basic |
$ |
0.17 |
$ |
0.20 |
$ |
1.76 |
$ |
1.57 |
||||||||||
Diluted |
$ |
0.17 |
$ |
0.20 |
$ |
1.76 |
$ |
1.56 |
||||||||||
Common dividends per share |
$ |
0.87 |
$ |
0.87 |
$ |
2.61 |
$ |
2.61 |
Outlook reconciliations: Year Ending |
Exhibit 1 |
|||||||||||||||||
(in millions, except per share data) |
||||||||||||||||||
Prior Outlook |
Current Outlook |
|||||||||||||||||
Low |
High |
Low |
High |
|||||||||||||||
FFO Reconciliation: |
||||||||||||||||||
Net income attributable to common stockholders |
$ |
994 |
$ |
1,020 |
$ |
894 |
$ |
913 |
||||||||||
Impairments and losses (gains) on real estate dispositions, net(1,2) |
(452) |
(452) |
(479) |
(479) |
||||||||||||||
Depreciation and amortization(1) |
938 |
938 |
978 |
978 |
||||||||||||||
NAREIT FFO attributable to common stockholders |
1,480 |
1,506 |
1,393 |
1,412 |
||||||||||||||
Normalizing items, net(1,3) |
8 |
8 |
110 |
110 |
||||||||||||||
Normalized FFO attributable to common stockholders |
$ |
1,488 |
$ |
1,514 |
$ |
1,503 |
$ |
1,522 |
||||||||||
Per share data attributable to common stockholders: |
||||||||||||||||||
Net income |
$ |
2.66 |
$ |
2.73 |
$ |
2.39 |
$ |
2.44 |
||||||||||
NAREIT FFO |
$ |
3.97 |
$ |
4.04 |
$ |
3.72 |
$ |
3.78 |
||||||||||
Normalized FFO |
$ |
3.99 |
$ |
4.06 |
$ |
4.02 |
$ |
4.07 |
||||||||||
Other items(1) |
||||||||||||||||||
Net straight-line rent and above/below market rent amortization |
$ |
(64) |
$ |
(64) |
$ |
(67) |
$ |
(67) |
||||||||||
Non-cash interest expenses |
15 |
15 |
13 |
13 |
||||||||||||||
Recurring cap-ex, tenant improvements, and lease commissions |
(78) |
(78) |
(84) |
(84) |
||||||||||||||
Stock-based compensation |
22 |
22 |
24 |
24 |
||||||||||||||
Notes: |
(1) Amounts presented net of noncontrolling interests' share and |
|||||||||||||||||
(2) Includes estimated gains on projected dispositions. |
||||||||||||||||||
(3) See Exhibit 2. |
Normalizing Items |
Exhibit 2 |
|||||||||||||||||||||
(in thousands, except per share data) |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||
|
|
|||||||||||||||||||||
2018 |
2017 |
2018 |
2017 |
|||||||||||||||||||
Loss (gain) on derivatives and financial instruments, net |
$ |
8,991 |
(1) |
$ |
324 |
$ |
(5,642) |
$ |
2,284 |
|||||||||||||
Loss (gain) on extinguishment of debt, net |
4,038 |
(2) |
— |
16,044 |
36,870 |
|||||||||||||||||
Preferred stock redemption charge |
— |
— |
— |
9,769 |
||||||||||||||||||
Incremental stock-based compensation expense |
— |
— |
3,552 |
— |
||||||||||||||||||
Nonrecurring income tax benefits |
— |
— |
— |
(7,916) |
||||||||||||||||||
Other expenses |
88,626 |
(3) |
99,595 |
102,396 |
117,608 |
|||||||||||||||||
Additional other income |
— |
— |
(10,805) |
— |
||||||||||||||||||
Normalizing items attributable to noncontrolling interests and |
724 |
(4) |
4,173 |
4,933 |
29,024 |
|||||||||||||||||
Net normalizing items |
$ |
102,379 |
$ |
104,092 |
$ |
110,478 |
$ |
187,639 |
||||||||||||||
Average diluted common shares outstanding |
374,487 |
370,740 |
373,638 |
367,894 |
||||||||||||||||||
Net normalizing items per diluted share |
$ |
0.27 |
$ |
0.28 |
$ |
0.30 |
$ |
0.51 |
||||||||||||||
Notes: |
(1) Primarily related to mark-to-market of Genesis HealthCare stock holdings. |
|||||||||||||||||||||
(2) Primarily related to extinguishment of term loan facility. |
||||||||||||||||||||||
(3) Primarily related to non-capitalizable transaction costs. |
||||||||||||||||||||||
(4) Primarily related to non-capitalizable transaction costs in joint ventures. |
FFO Reconciliations |
Exhibit 3 |
|||||||||||||||||||||
(in thousands, except per share data) |
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||
|
|
|||||||||||||||||||||
2018 |
2017 |
2018 |
2017 |
|||||||||||||||||||
Net income (loss) attributable to common stockholders |
$ |
64,384 |
$ |
74,043 |
$ |
656,487 |
$ |
575,118 |
||||||||||||||
Depreciation and amortization |
243,149 |
230,138 |
707,625 |
683,262 |
||||||||||||||||||
Impairments and losses (gains) on real estate dispositions, net |
(17,983) |
(1,622) |
(334,105) |
(263,207) |
||||||||||||||||||
Noncontrolling interests(1) |
(17,498) |
(16,826) |
(51,543) |
(51,887) |
||||||||||||||||||
Unconsolidated entities(2) |
13,220 |
9,989 |
38,753 |
43,066 |
||||||||||||||||||
NAREIT FFO attributable to common stockholders |
285,272 |
295,722 |
1,017,217 |
986,352 |
||||||||||||||||||
Normalizing items, net(3) |
102,379 |
104,092 |
110,478 |
187,639 |
||||||||||||||||||
Normalized FFO attributable to common stockholders |
$ |
387,651 |
$ |
399,814 |
$ |
1,127,695 |
$ |
1,173,991 |
||||||||||||||
Average diluted common shares outstanding |
374,487 |
370,740 |
373,638 |
367,894 |
||||||||||||||||||
Per share data attributable to common stockholders: |
||||||||||||||||||||||
Net income (loss) |
$ |
0.17 |
$ |
0.20 |
$ |
1.76 |
$ |
1.56 |
||||||||||||||
NAREIT FFO |
$ |
0.76 |
$ |
0.80 |
$ |
2.72 |
$ |
2.68 |
||||||||||||||
Normalized FFO |
$ |
1.04 |
$ |
1.08 |
$ |
3.02 |
$ |
3.19 |
||||||||||||||
Normalized FFO Payout Ratio: |
||||||||||||||||||||||
Dividends per common share |
$ |
0.87 |
$ |
0.87 |
$ |
2.61 |
$ |
2.61 |
||||||||||||||
Normalized FFO attributable to common stockholders per share |
$ |
1.04 |
$ |
1.08 |
$ |
3.02 |
$ |
3.19 |
||||||||||||||
Normalized FFO payout ratio |
84 |
% |
81 |
% |
86 |
% |
82 |
% |
||||||||||||||
Other items:(4) |
||||||||||||||||||||||
Net straight-line rent and above/below market rent amortization |
$ |
(19,164) |
$ |
(19,167) |
$ |
(48,940) |
$ |
(54,146) |
||||||||||||||
Non-cash interest expenses |
2,297 |
3,972 |
9,537 |
9,823 |
||||||||||||||||||
Recurring cap-ex, tenant improvements, and lease commissions |
(22,478) |
(16,651) |
(56,744) |
(45,720) |
||||||||||||||||||
Stock-based compensation(5) |
6,075 |
5,409 |
18,340 |
15,078 |
||||||||||||||||||
Notes: |
(1) Represents noncontrolling interests' share of net FFO adjustments. |
|||||||||||||||||||||
(2) Represents Welltower's share of net FFO adjustments from unconsolidated entities. |
||||||||||||||||||||||
(3) See Exhibit 2. |
||||||||||||||||||||||
(4) Amounts presented net of noncontrolling interests' share and |
||||||||||||||||||||||
(5) Excludes certain severance related stock-based compensation recorded in other expense and normalized incremental stock-based compensation expense (see Exhibit 2). |
View original content to download multimedia:http://www.prnewswire.com/news-releases/welltower-reports-third-quarter-2018-results-300740189.html
SOURCE
Aetna Reports Third-Quarter 2018 Results
Michigan Customers Get A Cost Break With New Business And Personal Check Writer Bundle
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News